Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of symptomatic therapy versus standard step-up care for low-impact psoriatic oligoarthritis
2018-001085-42Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone, triamcinolone acetonide in psoriatic arthritis (PsA), sponsored by University of Oxford. Status: unknown.
02
Drugs
methylprednisolonetriamcinolone acetonide
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2018-001085-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001085-42.